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Introduction 
ABSTRACT 
Background: Infection is a common cause of thrombocytopenia. Detection of 
thrombocytopenia associated with fever helps to narrow differential diagnosis and 
management of fever. It also helps to know the various complications of 
thrombocytopenia and its management and outcome of the patient. 
 
Methods: 100 patients aged > 12 years with fever and thrombocytopenia seen 
between December 2010 to November  2011 were included for this study. 
 
Results: Infection was the commonest cause of thrombocytopenia and dengue was the 
commonest infection. Bleeding manifestations were seen in 12 % of patients. 
PetechIae/purpura  as the commonest bleeding manifestation followed by gum 
bleeding.  Good recovery was noted in 92% while 8% had mortality. 50% of patients 
with platelet count below 20,000 does  not needed platelet transfusion. 
Conclusions: Infections, particularly dengue was the commonest cause of fever with 
thrombocytopenia. In majority of patients, thrombocytopenia  was transient and 
asymptomatic  but in significant number of cases there were bleeding manifestations. 
Spontaneous bleeding was noted in platelet count of < 20,000/mm3 in majority of 
patients, petechiae /purpura was seen in platelet count in range of 20,000-
40,000/mm3. On treating the specific cause drastic improvement in platelet count was 
noted during discharge and further follow-up. 
                                                                                    
 
 
INTRODUCTION 
Pyrexia is from the Greek  pyretos meaning fire.  Febrile is from 
the Latin word febris, meaning  fever, and archaically known as ague. 
 As early as the sixth century BC, fever was noted to be a cardinal sign of 
disease, as Akkadain cuneiform descriptions used a flaming brazier to 
symbolize both fever and the localization heat that occurs with inflammation 
(Atkins 1982).
(1)
 
 In the era of Hippocrates, fever was explained with the doctrine of the four 
humor: blood, phlegm, black bile, and yellow bile. Yellow bile was associated 
with the element of fire, and thus fever was considered to be caused by an 
excess of yellow bile. Fever was thought, at the time, to be beneficial sign 
during infection, because the increased heat or “fire” caused by the excess of 
yellow bile would cook the infection out of the patient (Atkins 1982, young & 
brown 1985). 
According to Mackowiak el al. ‘ after over a millennium of clinical 
investigation, there is not even a generally accepted(clinical) definition of 
fever’. 
The humoral concept of fever was the mainstay of clinical practice until the 
17
th
 century, when Harvey discovered that blood circulation through the body. 
Subsequently, the believe that fever was beneficial changed dramatically, and 
physicians thought that fever was produced in the body fluid as a result of 
                                                                                    
 
 
fermentation and putrefaction or because of friction from increased flow of 
blood        ( Atkins 1982).  
Fever was then consider to be synonymous with infectious disease as, until the 
mid- 19 century, most of these disease were grouped under the generic term of 
“ fever” . because patients with fevers were considered to be associated with 
disease and often death, they were frequently isolated in order to product the 
community, as a result, fever came to be feared, and thus warranted 
intervention. Fever is currently treated as ‘the orgin of, rather than the response 
to, an illness’. 
A growing body of research in immunology and neuro-physiology has led to 
the recent understanding that fever is generally an adaptive physiology 
response to some threat. This notion goes against the thinking of the last two 
centuries that fever was a sinister sign and required intervention to lower or 
control it. 
Fever has many important functions in the healing process: 
 Increased mobility of leukocytes. 
 Enhanced leukocytes phagocytosis. 
 Endotoxin effects decreased. 
 Increased proliferation of T cells. 
 Daniel G. Fahrenheit   used human body temperature as a reference point for 
his temperature scale, defining it to be 96°F in the early 18th century. Later 
                                                                                    
 
 
redefinition of his scale to use the boiling point of water as a reference point 
caused the numerical value for normal body temperature to drift. 
Carl Reinhold August Wunderlich  released his summary of the armpit, or 
axillary, temperatures of twenty five thousand people in 1861, and reported the 
mean to be 37.0 °C (98.6 °F), with a range of 36.25 °C (97.25 °F) to 37.5 
°C (99.5 °F). . 
Fever is defined as an elevation of the normal body temperature that above the 
normal circadian variation as a result of the changes in the thermoregulatory 
center, located in the hypothalamus and occurs in conjunction with an increase 
in hypothalamic set point e.g 37°c to 39°c  .   
          Thrombocytopenia is defined as platelet count <1,50,000/microliter. This 
is due to decreased production, increased destruction, increased sequestration 
in spleen. Of this infection is the most common cause. Fever with 
thrombocytopenia  narrows the differential diagnosis of the clinical entity. 
Infection like malaria , dengue, leptospirosis, typhoid, HIV, and miliary 
tuberculosis are some of the common causes of fever with thrombocytopenia. 
Therefore a well organised systemic approach that is carried out with an 
awareness of cause of fever with thrombocytopenia can shorten the duration of 
investigation and bring out diagnosis. 
Hence, need for study to know the causes and complications of fever with 
thrombocytopenia. 
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AIM OF THE STUDY 
 
1. To study of incidence of various etiological agents for patients getting 
admitted for fever with thrombocytopenia. 
 
2. To analyse relevant  epidemiological  data like seasonal variation 
 
 
3. To analyse the clinical feature among various positive cases. 
 
4. To analyse the investigation done on positive cases. 
 
 
5. To study the incidence of complication. 
 
6. To analyse about outcome of the patient. 
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REVIEW OF LITERATURE 
HISTORY OF FEVER: 
Fever is perhaps the most ancient hallmark of disease. It dates back as 
far as civilization itself.  For most of the history, fever was feared by ordinary 
people as a manifestation of punishment, induced by evil spirits or a marker of 
death. 
The oldest civilizations (Egyptian, Mesopotamian,   Chinese, Indian, 
and Greek)  demonstrated  extensive  knowledge of fever, but tended to view it 
as being  induced by evil spirits. Hence exorcism was used in many ancient 
cultures (to a lesser extent in Greek medicine) for the treatment of fever
.(1)
 
        Hippocratic writings, for example, contain evidence that fever was 
thought to be beneficial to the infected host. Rufus of Ephesus in the second 
century AD strongly advocated the beneficial role of fever. 
        Fever therapy was the principal form of treatment, not only for syphilis 
and gonorrhoea, but also for patients with rheumatoid arthritis and asthma. This 
belief, held for about 2000 years, should not be ignored. 
       Virtually all cultures use some form of "fever therapy" in the form of 
"saunas," or "sweat lodges," or "steam baths," or other ways to raise body 
temperature artificially.  This probably dates back to the Hippocratic era and is 
based on the "humoral" theory of disease, where one of the forms of therapy 
was to "cook" the bad "humour." 
                                                                                    
 
 
 
         Celsius, of the early Roman empire first suggested the possible 
relationship between fever and the cardinal manifestation of inflammation- 
heat, swelling, redness and pain. 
      The thermometer was not a single invention, however, but a development. 
       Galileo is often said to be the inventor of the thermometer, what he 
produced were thermoscopes.   He also discovered that objects (glass spheres 
filled with aqueous alcohol) of slightly different densities would rise and fall, 
which is now the principle of the Galileo thermometer
.(2) 
           The first person to put a scale on a thermoscope is variously said to 
be Francesco Sagredo
 
or Santorio Santorio
 
 in about 1611 to 1613. The word 
thermometer (in its French form) first appeared in 1624 in  La Récréation 
Mathématique by J. Leurechon, who describes one with a scale of 8 degrees. 
        In 1694 Carlo Renaldini proposed using them as fixed points on a 
universal scale. He described the normal diurnal variation of the body 
temperature. He  described the normal diurnal variation of the body, 
established 100.4F  as the upper limit of the normal range and gave the first 
quantitative definition of fever. Wunderlich is generally regarded as the father 
of clinical thermometer
.(3)
 
               Finally in 1724 Daniel Gabriel Fahrenheit  used mercury as the 
thermometric liquid, produced a temperature scale which now (slightly 
adjusted) bears his name. Mercury's thermal expansion is large and fairly 
                                                                                    
 
 
uniform, it does not adhere to the glass, and it remains a liquid over a wide 
range of temperatures. Its silvery appearance makes it easy to read.  
          In 1780, J. A. C. Charles, a French physician, showed that it is possible 
to establish a temperature scale based on a single fixed point rather than the 
two fixed- point scales, such as the Fahrenheit and Celsius scales. This brings 
us back to a thermometer that uses a gas as the thermometric medium. 
          Sir William Siemens, in 1871, proposed a thermometer whose 
thermometric medium is a metallic conductor whose resistance changes with 
temperature. The element platinum does not oxidize at high temperatures 
and has a relatively uniform change in resistance with temperature over a 
large range. The Platinum Resistance Thermometer is now widely used as a 
thermoelectric thermometer and covers the temperature range from about -
260° C to 1235° C. 
            The world's first temporal artery thermometer, a non-invasive 
temperature sensor which scans the forehead in about 2 seconds and provides a 
medically accurate body temperature was introduced by Dr. Francesco Pompei  
in 1999. 
        Pattrick Murphy and late barry wood were the first to obtained a purified 
form of endogenous pyrogen from rabbit peritoneal exudate cells.  
                                                                                    
 
 
       In 1972, Gery and Waksman described the chemical nature of “ 
lymphocyte-activating factor” which showed striking similarity with 
endogenous pyrogens. 
THERMOREGULATION 
Pathophysiology of fever:. 
               The febrile response is a complex physiologic reaction to disease 
involving a numerous endocrinologic and immunologic systems. 
Understanding the basic mechanisms  underlying this phenomenon helps to 
formulate rational approaches to  treatment and interventions.  
                      Fever is defined as an elevation of the normal body temperature  
that above  the normal circadian variation as a result of the changes in the, 
thermoregulatory center, located in the hypothalamus  and occurs in 
conjunction with an increase in hypothalamic set point e.g 37°c to 39°c  .   
          Normally heat is being continuously produced in the body, and also it is 
being lost continuously to the surroundings. When the rate of heat produced is 
equal to the rate of heat loss, the person is said to be heat balanced. But when 
there is is disturbance of equilibrium between the two, then the body 
temperature may rise leading to fever, or may fall leading to hypothermia.  
                         Once the hypothalamic set point is increased, neurons in 
vasomotor center are stimulated and vasoconstriction started.  The individual 
first notices vasoconstriction in the hand and feet. Shunting of blood away from 
                                                                                    
 
 
the periphery to the internal organs essentially decrease heat loss from the skin 
, and the person feel cold. For most fever, body temperature increase by 1°c to 
2°c .  Shivering, which increase heat production from the muscles, may begin 
at this time; however, shivering is not required if heat conservation mechanism 
raises body temperature sufficiently.  
             The process of heat conservation and heat production (shivering) 
continue until the temperature of body bathing the hypothalamic neurons 
matches the new thermostat setting. Once the point is reached , the 
hypothalamus maintain the temperature at the febrile level by the same 
mechanism of heat balance that function in the aferile state.  
                 When the hypothalamic set point is again reset downward in 
response to either a decrease in concentration of pyrogens or use of drugs, the 
processes of heat loss through vasodilation and sweating are initiated. Loss of 
heat by sweating and vasodilation continue until the body temperature at the 
hypothalamic level matches the lower setting. 
                The hypothalamus is central to this process, functioning as a 
thermostat, controlling thermoregulatory mechanisms that balance heat 
production with heat loss. Integral to the process are the heat-sensitive 
receptors located in the  preoptic area of the anterior hypothalamus. These 
receptors, which are sensitive to elevations in blood temperature, increase 
signal output as the temperature rises above a ﬁxed thermal set point (37.1°C 
average) and decrease output when the temperature drops below the set point.  
                                                                                    
 
 
Similar receptors are in the skin, spinal cord, and abdomen, sending impulses 
to the hypothalamus via the spinal cord. 
            With core body temperature elevations, the sympathetic system is 
inhibited, leading to vasodilation of skin vessels and stimulation of the sweat 
glands to facilitate evaporative loss. This process prevails until the body 
temperature matches the  thermal set point, when heat production matches heat 
loss. 
           Similarly, when body temperature is below the thermal set point, a 
variety of responses  are initiated to conserve and increase production  of heat. 
They include activation of the sympathetic nervous system to induce 
vasoconstriction  of skin blood vessels; inhibition of sweating; activation of the 
shivering center in the posterior  hypothalamus, thereby increasing muscle heat 
production; and secretion of neurotransmitters, which increase cell metabolism 
and, consequently, heat production
.(9)
 
NEURAL MECHANISM OF THERMOREGULATORY 
RESPONSE: 
No single center within the nervous  system controls body temperature.  Rather, 
thermoregulation is a process that involves a continum of neural structures and 
connections extending from the hypothalamus and limbic system through the 
lower brainstem and reticular formation to the spinal cord and sympathetic 
ganglia. Nevertheless, an area of the brain located in and near the rostral 
hypothalamus 
                                                                                    
 
 
seems to have a pivotal role in the process of thermoregulation.  Although 
generally  referred to as the  preoptic region, it actually includes the medial and 
lateral aspects of the preoptic area, anterior hypothalamus, and septum. 
Numerous studies extending more than 60 years have established that neurons 
located in this region are thermo sensitive and exert at least partial control  over 
physiologic and behavioural Thermoregulatory responses
.(8)
 
NEURONAL MODEL EXPLAINING FEVER: 
               Endogenous agents and various drugs affect temperature by altering 
the   activities of Hypothalamic  neurons. The best examples are pyrogens that 
cause fever by elevating the set point temperature.   Pyrogen  inhibition of  
warm sensitive neurons will raise the regulated set point temperature to a 
higher level such as 39
0
c. In response to the new set point temperature, 
thermoregulatory mechanism are activated to increase the pre optic temperature 
to 39
0
c, thus leading to development of fever. 
The whole body metabolic rate increase relative to the febrile state because, as 
result of  the Q10 effect, increase in temperature induces increase in all 
metabolic reaction.  
  
PYROGENS:  
              Pyrogens traditionally have been divided  into 2 general categories: 
those that originate outside the body (exogenous  pyrogens) and those derived 
from host cells (endogenous pyrogens). Exogenous pyrogens are, for the most 
part, microbes, toxins,  or other products of microbial origin,  whereas 
                                                                                    
 
 
endogenous pyrogens  are host cell–derived (pyrogenic) cytokines that are the 
principal central mediators of the febrile  response
.(5)
. 
    
EXOGENOUS PYROGENS:  
          Infection can be local or systemic in which Gram-positive or Gram-
negative organisms release cell wall products such as endotoxins, 
peptidoglycans, teichoic acids and others. Also, enterotoxins from 
Staphylococcus aureus and other products from Gram-positive organisms are 
released.  Gaining access to the circulation, for example in pneumonia entering 
the pulmonary vein and exiting via the carotid artery, microbial products reach 
the organum vasculosum laminae terminalis (OVLT) of the hypothalamus. The 
endothelium of the OVLT expresses LR receptors and microbial products such 
as endotoxins bind to their respective TLR on the OVLT and activate the 
endothelium.  Microbial products also bind to TLR on phagocytic cells 
(macrophages, neutrophils, Kupffer cells) or to TLR on systemic endothelial 
cells. Pyrogenic cytokines IL-1, TNF-α, IL-6 and other cytokines are 
synthesized, processed, released and gain access to the circulation. In the case 
of enterotoxins, binding occurs on the T-cell receptor (in which case 
enterotoxins are called superantigens) resulting in production of IL-1 and TNF-
α.. These pyrogenic cytokines enter the circulation and bind to their respective 
cytokine receptors on the OVLT. Activation of TLR and cytokine receptors 
induce COX-2, which results in synthesis of PGE2 
                                                                                    
 
 
on the brain side of the OVLT. Increases in brain PGE 2 stimulate the release 
of cAMP and other neurotransmitters triggering thermo sensitive neurons in the 
thermoregulatory center to raise the hypothalamic thermostatic set point. 
Neuronal signals to the cortex initiate behavioural changes in humans to 
conserve body heat (posturing, clothing and others).  Hypothalamic signals 
activate peripheral efferent nerves to blood vessels via the sympathetic 
pathways.  Vasoconstriction of the blood vessels supplying the peripheral 
circulation decrease heat loss and core temperature increases (measured as 
fever). The resulting increase in blood temperature is detected by the 
hypothalamic center, which maintains these mechanisms of heat conservation 
(and behavioral changes) until hypothalamic PGE 2 levels fall (as a result of 
inhibitors of COX-2 and/or COX-3). 
PGE2 RELEASE 
           PGE2 release comes from the arachidonic acid pathway. This pathway  
is mediated by the enzymes phospholipase A2 (PLA2), cyclooxygenase-
2 (COX-2), and prostaglandin E2 synthase(6). These enzymes  mediate the 
synthesis and release of PGE2.  PGE2 is the ultimate mediator of the febrile 
response.   During fever, levels of  PGE2 are elevated in hypothalamic tissue 
and the third ventricules. The circumventricular vascular organ surrounding the 
hypothalamic regulatory centers have the highest concentration of PGE2. 
Destruction of theses organs reduces the ability of pyrogens to produce the 
fever. Circulating cytokines by their systemic effect induces the synthesis of 
PGE2 which causes the fever.  
                                                                                    
 
 
           The increase in PGE2 in the periphery account for the nonspecific 
myalgias and arthralgias that often accompany fever. It is thought that some 
systemic PGE2 escapes destruction by the lung and gain access to the 
hypothalamus via the internal carotid. However, it is the elevation in the brain 
that starts the process of raising the hypothalamic set point for core 
temperature.  
          There are four receptors for PGE2, and each signals the cell in different 
ways. Of the four receptors, the third(EP-3) is essential for fever: when the 
gene for this receptor is deleted in mice, no fever follows the injection of IL-1 
or endotoxin. Deletion of the other PGE2 receptor genes leaves the fever 
mechanism intact. Although PGE2 is essential for fever, it is not a 
neurotransmitter. Rather, the release of PGE2 from the brain side of the 
hypothalamic endothelium triggers the PGE2 receptor on glial cells, this 
stimulation results in the rapid release of cyclic AMP, Which is a 
neurotransmitter. The release of cyclic AMP from glial cells activates neuronal 
endings from the thermoregulatory center  extend in to the area. The elevation 
of cyclic AMP is thought to account for changes in the hypothalamic set point 
either directly or indirectly. Distinct receptors for microbial product are located 
on the hypothalamic endothelium. These receptor are called  toll- like receptors 
and are similar in many ways to IL-1 receptors. The direct activation of toll-
like receptor also result in PGE2 production and fever
.(9)
   
      
                                                                                    
 
 
 
CYTOKINES AS ENDOGENOUS PYROGENS: 
                In essence, all endogenous pyrogens are cytokines, molecules that are 
a part of the innate immune system. They are produced by phagocytic cells and 
cause the increase in the thermoregulatory set-point in the hypothalamus. 
Major endogenous pyrogens are interleukin 1 (α and β), interleukin 6 (IL-6) 
and tumour necrosis factor-alpha. Minor endogenous pyrogens 
include interleukin-8, tumour necrosis factor-α,  tumour necrosis factor-
β, macrophage inflammatory protein-α and macrophage inflammatory protein-
β as well as interferon-α, interferon-β, and interferon-γ.  
           These cytokine factors are released into general circulation, where they 
migrate to the circumventricular organs of the brain due to easier absorption 
caused by the blood-brain barrier's reduced filtration action there. The cytokine 
factors then bind with endothelial receptors on vessel walls, or interact with 
                                                                                    
 
 
local microglial cells. When these cytokine factors bind, the arachidonic acid 
pathway is then activated. 
            Some endogenous molecules can also induce endogenous pyrogens not 
requiring exogenous stimuli, for e.g. antigen-antibody complexes, certain 
androgenic steroid metabolites, inflammatory bile acids, and some lymphocytes 
product. 
INTERLEUKIN (IL) -1 
            IL-1α is produced mainly by activated macrophages, as well 
as neutrophils, epithelial cells, and endothelial cells. In general, Interleukin 1 is 
responsible for the production of inflammation, as well as the promotion of 
fever and sepsis. 
Interleukin 1 was discovered by Gery in 1972.
 
 He named it lymphocyte-
activating factor (LAF) because it was a lymphocyte  mitogen. It was not until 
1985 that interleukin 1 was discovered to consist of two distinct proteins, now 
called interleukin-1 alpha and interleukin-1 beta.  
           IL-1α is also known as fibroblast-activating factor (FAF), lymphocyte-
activating factor (LAF), endogenous pyrogen (EP), osteoclast-activating factor 
(OAF).  
In Vivo Shortly after an onset of an infection into organism, IL-1α activates a 
set of immune system response processes. 
 
                                                                                    
 
 
 induces synthesis of proteases, subsequent muscle proteolysis, release of 
all types of amino acids in blood and stimulates acute phase 
proteins synthesis 
 stimulates fibroblasts proliferation 
 increases blood neutrophils 
 induces cycloxygenase synthesis and prostaglandin PGE2 release 
 activates lymphocyte proliferation and induces fever 
 changes the metallic ion content of blood plasma by increasing copper 
and decreasing zinc and iron concentration in blood 
FEBRILE PATTERN: 
Continuous fever: Temperature remains elevated above normal without 
touching the baseline and the fluctuation does not exceed 0.6c in 24 
hours, e.g. lobar pneumonia, typhoid,urinary tract infection, brucellosis, 
or typhus. Typhoid fever may show a specific fever pattern, with a slow 
stepwise increase and a high plateau.  
      Continuous fever 
 
 
                                                                                    
 
 
 
Intermittent fever:  The elevated  temperature  touch the baseline in between. 
In hectic or septic type of intermittent fever, the diurnal variation  elevation is 
extremely large, as occurs in septicaemia.  Quotidian fever is a hectic fever 
occurring daily. e.g. malaria, kala-azar, or septicemia. Following are its types  
 Quotidian fever, with a periodicity of 24 hours, typical of Malaria 
 Tertian fever occurs on the first and third day, e.g P. Vivax and ovale, 
falciparum. 
 Quartan fever  occurs on first and fourth day  e.g Plasmodium malariae 
 Intermittent fever pattern 
 
 
Remittent fever:  the temperature fluctuation exceeds 0.6
0
c, but without 
touching the baseline e.g., infective endocarditis. 
                                  
  
                                                                                    
 
 
Remittent fever pattern 
 
Relapsing fever pattern:  
Febrile episode are separated by normal temperature for more than several 
days, e.g borrelia infection, rat bite fever. 
                                             Borrelia( relapsing pattern) 
 
Pel-Ebstein fever:  It is a type of fever lasting for 3 to 10 days followed by an 
afebrile period of 3 to 10 days e.g hodgkins lymphomas   
 
 
 
                                                                                    
 
 
Malaria fever chart 
 
  
                                                                                    
 
 
SADDLE BACK (BIPHASIC FEVER): 
                       With several days of fever, gap of reduced fever of about 1 day, 
and several additional days of fever, this type characterises dengue and yellow 
fever, rift valley fever, Colorado tick fever and viral fever like influenza, polio.    
  Fever magnitude: 
                   Most infectious disease produce temperature between 99
0
F to 
106°F .  However some patient with infectious disease remain afebrile. These 
includes immunocompromised host, those with CRF, elders, alcoholic. 
             Hyperpyrexia is a elevation of body core temperature greater than or 
equal to 41 °C (106.7 °F) due to inadequate dissipation of heat. It is a medical 
emergency, since they are prone for sudden cardio respiratory arrest. Such a 
high temperature is considered a medical emergency as it may indicate a 
serious underlying condition or lead to significant side effects. The most 
common cause is an intracranial haemorrhage.
[15]
 Other possible causes 
include sepsis, Kawasaki syndrome,
[17]
 neuroleptic malignant syndrome, drug 
effects, serotonin syndrome, and thyroid storm.
[16]
 Infections are the most 
common cause of fever, however as the temperature rises other causes become 
more common.  Infections commonly associated with hyperpyrexia 
include: roseola, rubeola and enteroviral infections. 
  
                                                                                    
 
 
WHY ARE FEVER TEMPERATURE 0VER 106°F RARE? 
                Hippocrates maintained that “ heat is the immoratal substance of life 
endowed with intelligence....” hence, heat must also be refrigerated by 
respiration and kept within bounds if source or principle of life is to persist; for 
if refrigeration is not provided the heat will consume itself’. 
THROMBOCYTOPENIA 
                      Platelets, or thrombocytes (from Greek , "clot" "), are small, 
irregularly shaped clear cell fragments (i.e. cells that do not have 
nucleus containing DNA), 2–3 µm in diameter, which are derived from 
fragmentation of precursor megakaryocytes.  The average lifespan of a platelet 
is normally just 5 to 9 days. 
 The physiological range for platelets is (150–400)×10
9
 per liter. 
 Around 10
11
 platelets are produced each day by an average healthy adult. 
Megakaryocyte and platelet production is regulated by thrombopoietin, a 
hormone usually produced by the liver and kidneys. 
                                                                                    
 
 
PRODUCTION OF PLATELET
 
TABLE: 1    
Causes of thrombocytopenia: 
Decreased marrow 
production 
Marrow infiltration with tumours, aplastic, 
hypoplastic anemia,  , B12 or folic acid deficiency, 
viral infection, thrombopoietin deficiency. 
Spleenic  sequestration 
of circulating platelet 
hypersplenism 
Hypothermic anaesthesia 
increased destruction of 
circulating platelet 
Non immune mechanism like DIC, TTP, HUS, massive 
blood transfusion,  
 immune mechanism like ITP, SLE, HIV, drug induced, 
sarcoidosis  autoimmune thyroiditis. 
 
                                                                                    
 
 
THROMBOCYTOPENIA ASSOCIATED WITH 
INFECTION: 
Purpura was recognised as a manifestation of peltissutial fever 2000 year ago. 
Several factor known to cause bleeding in associated with infection of which 
thrombocytopenia is the common cause. 
Viral causes: 
           Dengue,  HIV, HSV, CMV, Hanta virus. 
Mechanism: 
                Many virus causes thrombocytopenia, out of this dengue is the most 
common cause
.(9)
 
            Most patients who develop dengue hemorrhagic fever or dengue 
hemorrhagic shock syndrome have had prior infection with one or more dengue 
serotypes. When an individual is infected with another serotype (ie, secondary 
infection), these non neutralizing antibodies recognize the dengue virus but do 
not neutralize or inhibit virus replication. 
Instead, the virus and antibody form an antigen-antibody complex. This 
complex is recognized by receptors on macrophages, which then internalize the 
immune complex and allow the virus to replicate unchecked. This phenomenon 
is called antibody-dependent enhancement. 
The affected macrophages release vasoactive mediators that increase vascular 
permeability, leading to vascular leakage, hypovolemia, and shock. This 
                                                                                    
 
 
mechanism, along with individual host and viral genome variations, plays an 
active role in pathogenesis. 
Some researchers suggest that T-cell immunopathology may play a role, with 
increased T-cell activation and apoptosis. Increased concentrations of 
interferon have been recorded 1-2 days following fever onset during 
symptomatic secondary dengue infections. The activation of cytokines, 
including TNF-alpha, TNF receptors, soluble CD8, and soluble IL-2 receptors, 
has been correlated with disease severity
.(20) 
Mechanism of thrombocytopenia in HIV:  
         Thrombocytopenia is found in 3-40% of individuals with HIV infection.  
It can be the first presentation, and may occur at any stage of HIV infection. 
HIV-related thrombocytopenia can be caused by the following: 
Immune thrombocytopenic purpura 
Immune thrombocytopenic purpura (ITP) is very common in HIV infection. 
This condition, characterised by very low platelet counts with an otherwise 
normal haematocrit and white blood cell count, is caused by an immune-
mediated destruction of platelets. Patients with ITP may bruise easily or have 
petechiae, and bleeding from the  gums or other sites. Serious haemorrhage is 
uncommon
.(27,29)
 
Thrombotic thrombocytopenic purpura 
Thrombotic thrombocytopenic purpura (TTP) is very rare, in comparison to 
ITP.  
                                                                                    
 
 
TTP  presents with fever, haemolytic anaemia, thrombocytopenia, renal and 
neurological problems, caused by thrombi forming in small blood vessels 
affecting multiple organs. The diagnosis is confirmed by fragmented red blood 
cells (schistocytes) found on peripheral blood smear. Pregnancy and 
disseminated intravascular coagulation should be excluded. TTP is a medical 
emergency requiring plasmapheresis
.(16)(34,35)
 
Case study 8.1 
  
PATHOGENSIS 
 
 
BACTERIAL CAUSE: 
  Gram +ve and –ve septicaemia, military tuberculosis, leptospirosis, 
typhoid, mycoplasma pneumonia. 
          Tuberculosis is one of the world’s most challenging communicable 
diseases. Bone marrow changes include changes in marrow cellularity 
                                                                                    
 
 
manifesting as myeloid hyperplasia that occurs more commonly with 
pulmonary tuberculosis, plasmacytosis, megaloblastic changes in cell lineages, 
and marrow aplasia. Miliary tuberculosis is associated with histiophagocytosis 
of all cell lineages and caseating granuloma formation in 60–70% cases. Other 
marrow changes in tuberculosis include marrow necrosis and myelofibrosis
.(18)
     
Thrombocytopenia in tuberculosis can occur due to marrow suppression as a 
side effect of histiophagocytosis as described above, tuberculosis complicated 
by thrombotic thrombocytopenic purpura (TTP), or disseminated intravascular 
coagulopathy (DIC), or due to immune-mediated platelet destruction. The 
immune basis of tuberculosis-induced thrombocytopenia is supported by the 
presence of either the platelet antigen-specific antibodies or platelet surface 
membrane IgG, or by response to immunomodulatory therapy .
(19)
 
Protozoal causes: 
           Thrombocytopenia seen in complicated falciparum malaria is due to 
disseminated intravascular coagulation along with platelet endothelial 
activation,  but the one seen in uncomplicated malaria like P. vivax has 
multifactorial etiology. Few postulated mechanisms are macrophage activation 
leading to platelet destruction, increased levels of cytokines, immunological 
destruction due to antiplatelet IgG6, oxidative stress, shortened platelet life 
span in peripheral blood and sequestration in nonsplenic areas and partly due to 
pseudo thrombocytopenia due to clumping of platelets
.(12, 13)
 
  
                                                                                    
 
 
Other cause:  
                     Certain haematological condition also caused thrombocytopenia 
by marrow infiltration. 
General view of burden of  common infectious causes in india: 
Dengue: 
Dengue fever (DF) is the most common arthropod-borne viral disease and is 
one of the most important emerging infectious diseases of urban and peri-urban 
areas of tropical regions.  
         Since the 18th century, dengue has caused repeated epidemics worldwide. 
H. Graham in 1903 implicated Aedes aegypti as the vector for the disease and 
the virus was isolated in 1944 by Albert Sabin et al1. Dengue haemorrhagic 
fever gained nosologic status in 1954 and subsequently became endemic in 
many areas of tropical Asia. India belongs to category B, where dengue is an  
emerging disease with cyclical epidemics becoming more frequent. There have 
been repeated epidemics with the latest outbreak in the capital city of Delhi and 
various other states of India
.(30)
 
AETIOLOGY 
(a) Causative agent: 
Four dengue viruses (types 1-4) within the genus flavivirus and family 
flaviviridae, are the causative agents. All four subtypes are found in India. 
Dengue virions are small particles with lipoprotein envelope and nucleocapsid 
of single stranded RNA genome with positive polarity. There is a close 
                                                                                    
 
 
antigenic similarity between the four serotypes but the cross protection in 
humans is at best partial and transient. 
(b) Transmission: 
               Reservoir of infection is both man and mosquito. The transmission 
cycle is “Man-Mosquito-Man”. Aedes aegypti is the principal vector, the other 
less important vectors being Aedes albopictus, Aedes polynesiensis, and several 
species of Aedes scutellaris complex1, 2. The extrinsic incubation period is 8-
11 days, with mosquitoes remaining infected for life. Aedes aegypti – also 
called the “tiger mosquito” – is a daybiter with limited flight range, and breeds 
in fresh water collected indoors and peri-domestically in tropical areas. The 
outbreaks coincide with the monsoon. The epidemiologic significance of 
transovarian mosquito cycle and jungle transmission cycle is unknown
.(31,32)
 
EPIDEMIOLOGY 
      Dengue affects more than 100 countries all over the world except Europe. 
In India, the first recorded outbreak of dengue fever was in 1812 and 
serological survey was conducted in 1952. In 1996, an outbreak involving 
10,000 cases occurred in New Delhi; 400 deaths were reported in the 
outbreak.(
33)
 
MALARIA: 
           Malaria is a protozoan disease transmitted by the bite of infected 
anopheles mosquitoes. It is the most important of the parasite disease of 
human, with transmission in 107 countries containing 3 billion people and 
causing 1-3 million death each year. Approximately 5% of the world 
                                                                                    
 
 
population is infected.  Malaria has infected humans for over 50,000 years, 
and Plasmodium may have been a human pathogen for the entire history of the 
species. Close relatives of the human malaria parasites remain common in 
chimpanzees. Some new evidence suggests that the most virulent strain of 
human malaria may have originated in gorillas.  
References to the unique periodic fevers of malaria are found throughout 
recorded history, beginning in 2700 BC in China.
 
 Malaria may have 
contributed to the decline of the Roman Empire, and was so pervasive in Rome 
that it was known as the "Roman fever".
  
A number of regions in ancient Rome 
were considered at-risk for the disease because of the favourable conditions 
present for malaria vectors. This included areas such as: southern Italy, the 
island of Sardinia, the Pontine Marshes, the lower regions of coastal Etruria 
and the city of Rome along the Tiber River. The presences of stagnant water in 
these places were preferred by mosquitoes for breeding grounds. Irrigated 
gardens, swamp-like grounds, runoff from agriculture, and drainage problems 
from road construction led to the increase of standing water.  
                  The term malaria originates from Medieval Italian: mala aria — 
"bad air"; the disease was formerly called ague or marsh fever . 
(22)
 
DISCOVERY OF THE PARASITE: 
            On 20 october 1880 charles Louis alphonse was examining the fresh 
blood of patient with ague, and observed moving bodies which he surmised 
correctly were  parasites of red blood cells. The transmissibility of the infection 
in blood was proved 4 years later, by Gerhardt, but the route of natural 
                                                                                    
 
 
infection was not discovered until next decade. He, therefore, proposed that 
malaria is caused by this organism.
 
 For this and later discoveries, he was 
awarded the 1907 Nobel Prize for Physiology of Medicine. The malarial 
parasite was called Plasmodium by the Italian scientists Ettore Marchiafava and 
Angelo Celli. 
              Malaria is a mosquito-borne infectious disease of humans and other 
animals caused by eukaryotic protists of the genus Plasmodium. The disease 
results from the multiplication of Plasmodium parasites within red blood cells, 
causing symptoms that typically include fever and headache, in severe cases 
progressing to coma or death. It is widespread in tropical and subtropical 
regions, including much of Sub-Saharan Africa, Asia, and the Americas. 
Five species of Plasmodium can infect and be transmitted by humans. Severe 
disease is largely caused by Plasmodium falciparum while the disease caused 
by Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae is 
generally a milder disease that is rarely fatal. Plasmodium knowlesi is a 
zoonosis that causes malaria in macaques but can also infect humans
.(23) 
              There were an estimated 225 million cases of malaria worldwide in 
2009.
[8]
. An estimated 781,000 people died from malaria in 2009 according to 
the World Health Organization's 2010 World Malaria Report, accounting for 
2.23% of deaths worldwide.
 
 Ninety percent of malaria-related deaths occur in 
sub-Saharan Africa, with the majority of deaths being young 
children. Plasmodium falciparum, the most severe form of malaria, is 
responsible for the vast majority of deaths associated with the 
                                                                                    
 
 
disease.
[10]
 Malaria is commonly associated with poverty, and can indeed be a 
cause of poverty
[11]
 and a major hindrance to economic development.
(24,25) 
LEPTOSPIROSIS:
 
                Leptospirosis (also known as Weil's syndrome,  canicola fever,  
canefield fever,  nanukayami fever,  7-day fever, Rat Catcher's Yellows, Fort 
Bragg fever, black jaundice  and Pretibial fever)  is caused by infection with 
bacteria of the genus Leptospira, and affects humans as well as other mammals, 
birds, amphibians, and reptiles. 
              The role of the rat as a source of human infection was discovered in 
1917. while the potential for leptospiral disease in dogs was recognized, but 
clear distinction between canine infection with L. interrogans serovars 
icterohaemorrhagiae and canicola took several years. Leptospirosis in livestock 
was recognized some years later. The infection is commonly transmitted to 
humans by allowing water that has been contaminated by animal urine to come 
in contact with unhealed breaks in the skin, the eyes, or with the mucous 
membranes. Outside of tropical areas, leptospirosis cases have a relatively 
distinct seasonality with most of them occurring in spring and autumn
.(15)
 
COMPLICATION: 
Platelet count>1 lakh, are usually asymptomatic and bleeding time 
remains normal.  Platelet count of 50,000 and 1,00,000 cause mild prolongation 
of the bleeding time only after sever trauma. 
                                                                                    
 
 
Platelet count of<50,000 have easy bruising , manifested by skin purpura after 
minor trauma. 
Platelet count <20,000 have spontaneous bleeding, they usually have petechiae 
and may have intracranial or spontaneous internal bleeding. 
INVESTIGATION: 
Many investigation should be included to work up of patient with fever and 
thrombocytopenia  which including biochemical test, peripheral smear, 
haemogram etc. 
a) Complete haemogram: 
1. ESR: >30mm/hr suggest – TB; malignancy. It is a non specific 
test, it is raised in most conditions. 
2. Leucopenia: early dengue 
3. Leucocytosis: predominately neutrophils indicates septicaemia. 
4. Peripheral smear:  malarial parasites, malignant cells.  
b) Rapid spot test: 
           For plasmodium vivax and plasmodium palciparum 
            It is very sensitivity test. 
c) WIDAL – tube method for identification of enteric fever 
d) IgM ELISA dengue:  
e) IgM ELISA leptospirosis antibody; 
f) Blood culture: at least 3 blood culture sample should be taken. 
g) Bone marrow aspiration/ biopsy: for leukemia, lymphoma etc.  
                                                                                    
 
 
So in patient with fever and thrombocytopenia with renal and liver parameter 
being abnormal, then consider following 
1. Leptospirosis 
2. Malaria 
3. Dengue 
4. Septicaemia with multi organ failure. 
Platelet count should also be repeated and observed for bleeding manifestation. 
Platelet transfusion are indicated when platelet count is <20,000. Treating the 
underlying condition will result in drastic improvement of platelet count and its 
complication. 
 
 
 
 
 
 
 
                                                                                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Materials and Methods 
  
                                                                                    
 
 
MATERIALS AND METHODS 
The present study was done in patients admitted to Coimbatore medical  
college ,Coimbatore,  tamilnadu over a period of one year. 
SELECTION CRITERIA: 
All patients more than 12years of age with fever ( temperature >99.9
0
F) and 
platelet count less than 1,50,000 cells/cu.mm. 
No. Of patients selected: 100 
EXCLUSION CRITERIA: 
All   patients less than 12 yrs of age.  
All  patients with  thrombocytopenia  without  fever. 
Diagnosed cases of platelet disorders and dysfunction 
Patients on treatment with antiplatelet drugs and other drugs causing 
thrombocytopenia. 
PEROID OF STUDY: 
All patients were age of ≥ 12 years  who were admitted as 
 
in-patients  between  dec 2010 to nov 2011 in the Medicine Department in 
Coimbatore Medical College  Hospital  for fever  with thrombocytopenia. 
 STUDY DESIGN:     Prospective study 
  
                                                                                    
 
 
METHODS 
                   All patients admitted in Coimbatore Medical College Hospital with 
fever and thrombocytopenia were evaluated. History was taken regarding 
duration of fever, occupation and history of travel. Symptoms other than fever,  
headache, nausea, vomiting, abdominal pain, diarrhea, cough, , anorexia, 
myalgia, gum bleeding, hemetemesis , conjunctival suffusion, oliguria, 
hematuria, loss of weight,  etc., were noted. 
Signs like rashes, signs of dehydration, petechiae, jaundice, 
lymphadenopathy, hepatomegaly, splenomegaly, anaemia, abdominal 
tenderness, added sounds in lungs  , altered sensorium, etc., were also  noted. 
Investigations like complete hemogram, ESR, Liver function tests, 
routine urinary examination, urine for bile  salts and bile pigments, Renal 
parameters like blood urea, serum creatinine, serum electrolytes, peripheral 
smear , xray chest, USG abdomen were done on admission. 
Other special investigations like peripheral smear for MP, dengue 
serology, widal study, IgM antibody for leptospirosis, sputum AFB, ELISA for 
HIV1 and 2, blood culture and urine culture, bone marrow aspiration. 
During the hospital stay, all the patients were subjected repeat CBC 
once in 2 days. The renal function tests were repeated every third day 
unless the patient developed ARF for whom the tests were done daily. 
Follow up of all patients regarding treatment and outcome were done 
during the hospital stay. 
                                                                                    
 
 
The causes of fever with thrombocytopenia are so numerous, a simple 
workable classification is presented in- 
1. Viral causes:  
                  CMV, HSV, HIV, hantana, dengue, parvo-B19 
2. Bacteria:  
                 Gram +ve and gram-ve septicaemia, military tuberculosis, 
leptospirosis, typhoid. 
3. Protozoal causes: 
                        Malaria 
4. Others:  
               Leukemia, lymphoma etc 
 
 
 
 
  
 
 
 
 
 
 
                                                                                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Observations and Results 
 
                                                                                    
 
 
RESULTS AND ANALYSIS 
 
      Analysis  of  clinical  symptoms,  laboratory  profile and  complication  of  
100  patients  presented   with   fever  with  thrombocytopenia   admitted  at  
Coimbatore  medical  college  and   hospital,   between December 2010  to  
November 2011,  who  met  the inclusion   criteria  was  done. 
                                                             Total number of cases admitted with 
fever with thrombocytopenia is 100. Out of this 100 cases, 70 cases were male 
and 30 cases were female with male female ratio is 2.3:1. Most of the cases 
admitted between age 26 to 35. The mean age for male and female cases was 
33.76 and 33.1 respectively. 
The age and sex distribution is given below fig 1 , 2, and 3. 
AGE WISE DISTRIBUTION OF CASES 
Table 2 
AGE 
 
  
NO. OF CASES PERCENTAGE 
12 -25 22 22% 
26-35 38 38% 
35-45 32 32% 
>45 8 8% 
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SEX WISE DISTRIBUTION 
Table 3 
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Out of 100 cases, 50% of fever 
September  and November
below. 
 
 
 
 
 
 
 
 
GRAPH 2 
 
SEASONAL VARIATION 
with thrombocytopenia  admitted  between  
 month.  The seasonal variation distribution is given 
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GRAPH 3 
 
 
DISTRIBUTION OF SYMPTOMS       
Most common presenting symptoms is fever with chills and rigor, myalgia 
followed by abdominal pain and vomiting. 
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SI 
NO 
SYMPTOMS
1  FEVER 
2 CHILLS AND RIGOR
3 MYALGIA 
4 ABD PAIN/ VOMITTING
5 COUGH  
6 BREATHLESSNESS
7 BLEEDING GUM
8 RASHES 
9 GI BLEEDING
10 CONJUCTIVAL SUFFUSION
11 LOSS OF WEIGHT
12 ALTERED SENSORIUM
                                           
0
20
40
60
80
100
120
 
 
TABLE 4 
 NO OF 
CASES 
100 
 62 
63 
 28 
8 
 25 
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SI NO 
1 DEHYDRATION
2 PALLOR 
3 JAUNDICE
4 HYPOTENSION
5 HEPATOMEGALY
6 SPLENOMEGALY
7 PLEURAL EFFUSION
8 HAEMORRAGHIC 
FUNDUS 
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DISTRIBUTION OF SIGNS: 
TABLE 5 
SIGN NO OF CASES 
 38 
12 
 10 
 11 
 10 
 9 
 9 
4 
SIGNS DISTRIBUTION 
GRAPH -5 
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DISTRIBUTION OF ETIOLOGICAL AGENTS
 
Out of 100 cases, most common 
dengue fever(42) , followed  by malaria (21) and leptospirosis(11).  Etiological 
distribution is given below
ANALYSIS OF LAB INVESTIGATION
COMPLETE HEMOGRAM
• Mean hemogloblin value was 
• Range 5.5- 14.4gm%
PLATELET COUNT:
• Mean platelet count was 52,175.00
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• Ranges from 5,500/μL to 1,20,000/μL 
• Out of 100 cases with thrombocytopenia (<1,50,000), 60 cases 
were above 40,000. 17 cases were between 20,000 to 40,000. But  
23 cases were below 20,000. 
TABLE 6 
PLATELET COUNT 
SI.NO 
PLATELET 
COUNT 
NO OF CASES PERCENTAGE 
1 <1,50,000 100 100% 
2 >40,000 60 60% 
3 20,000 TO 40,000 17 17% 
4 <20,000 23 23% 
 
PLATELET COUNT       
GRAPH 6 
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HAEMATOCRIT: 
• Mean haemotocrit value  was  32.05 
• The value ranges from 21 to 55. 
 
RENAL FUNCTION TEST: 
Out of 100 cases, 12 cases had elevated renal parameter. Out of this 12 cases, 8 
patients renal parameter improved with rehydration alone. Only 4 cases  who 
needed nephrologist’s intervention and dialysis. 
                                  
TABLE 7 
 
 
 
 
 
 
 
LIVER FUNCTION TEST: 
Out of 100 cases, 13 cases had elevated liver function test. Out of this 13 cases 
, 6 patient  had  bilirubin level > 5.0mg/dl.  Out of this 6 cases, 3 patients were 
died. 
Distribution of bilirubin level, SGOT, SGPT, ALP is given below. 
SI  NO BLOOD UREA NO  OF CASES 
1 <40 88 
2 40-60 5 
3 60-100 2 
4 >100 5 
                                                                                  
 
                         
     
LFT 
Sr. bilirubin 
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SGPT(U/L) 
ALP(IU/L) 
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  TABLE 8                         
LIVER FUNCTION TEST 
MEAN 
2.14mg/dl 0.8
53.10 
57.54 
82.53 
 
USG ABDOMEN:                
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No of patients expired is   
Mortality rate is   -8%.
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DISCUSSION 
          For a study of fever with thrombocytopenia, patient must satisfy above 
mentioned criteria’s, prospective case collection is necessary and careful follow 
up is warranted. The three conditions allow the delineation of standard study 
population. 
        Out of 100 cases admitted with history  of fever with thrombocytopenia, 
most common causes is infectious. 
       Out of this infectious condition,  dengue is the most common cause (42%), 
second most common cause is malaria 21%. 
      Most of the patients were in the working group aged between 25 
and 35 years. Further most of them were males (2.3:1). 
      Further as far as the Seasonal Distribution of cases were concerned, 
most of the cases were admitted during the months of September, October 
and November  during which the Northwest monsoon is active in Tamil 
Nadu though sporadic cases were also seen during other months of the 
year. 
            Among symptoms other than fever, myalgia is most common 
63%, followed by chills and rigor 62%. 
    Among bleeding manifestation, purpura 12% is the most common 
followed by bleeding gum 10% and GI bleeding is least 3%. 
                                                                                    
 
 
                 Out of 100 cases,  38%  patients had dehydration at the time of 
admission. Among 38% , 11% patients had hypotension during admission. 
Most of the patients improved with treatment except few. 
                    Among 100 cases with reduced platelet count, 60% cases had 
platelet above 40,000.  17%  case had platelet between 20,000 to 40,000. 
Remaining 23% cases had platelet below 20,000. 
              Among 17 patient with platelet count between 20,000 and 40,000, 15 
patients cured without  blood transfusion. Only 2 patients needed blood 
transfusion. 
            Among 23 patient  with <20000 platelet count,  12 patients improved 
without platelet transfusion.  So only 11 patients actually  need blood 
transfusion. Out of this 11 patients,  5 patients  platelet count improved with 
FFB alone.  So 6 out of 23 patients actually needed platelet transfusion. 
Platelet count No of cases. 
No of cases improved 
without  bl. 
Transfusion 
No of cases improved   
after  bl. Transfusion 
40,000 -1,50,000 60 60 0 
20,000-40,000 17 15 2 
<20,000 23 12 11 
 
                A similar type of study conducted in India by Nair Ps, Jain A at 
st.Stephen’s hospital, New delhi, for period of one and half year. A total 
study of 109 cases  were studied with same criteria as in our study
.(17)
 
                                                                                    
 
 
             Septicaemia 29% was the leading cause of fever associated with 
thrombocytopenia. Second common cause  was enteric  fever followed by 
dengue, malaria.  
 Comparison of nair study and our study 
Disease category Nair study Our study 
Septicaemia 29 26.6% 2 2% 
Dengue/ VHF 15 14.7% 42 42% 
Malaria 10 9.2% 21 21% 
Haematological  17 15.6% 5 5% 
others 20 18.3% 30 30% 
 
Distribution of platelet 
count 
Nair study Our study 
0-20,000 19 17.5% 23 23% 
20,000-40,000 28 25% 17 17% 
40-1,50,000 62 56.8% 60 60% 
 
 
 
 
                                                                                    
 
 
In conclusion our study of fever with thrombocytopenia reveals that  
     Infection is the most commonest cause, among infections , dengue  is the 
common cause because of seasonal and regional variation. Second most 
common cause is malaria, in that p.vivax is more common.  Petechiae is 
common bleeding manifestation. Blood transfusion is not needed for all the 
cases even when platelet is below 20,000. Acute renal failure is the common 
complication. 
 
          
 
 
 
 
 
 
 
 
 
 
                                                                                    
 
 
SUMMARY 
A  prospective study of 100 patients, who had fever and thrombocytopenia was 
done in our hospital. The inclusion and exclusion criteria were followed 
according to the criteria’ mentioned in the material and methods of the study. 
1. The age range of the patient was 18-62 years, with male and female ratio 
being 2.3:1. 
2. Most of the cases admitted during September to December. 
3. Among symptoms other than fever, myalgia is most common 63%, 
followed by chills and rigor 62%. 
4. Among bleeding manifestation, purpura 12% is the most common 
followed by bleeding gum 10% and GI bleeding is least 3%. 
5. A definitive diagnosis was made in 95% of the case. 
6. Among the diagnosed case, dengue is most common cause of fever with 
thrombocytopenia (42%). Out of this 42 cases, 37 cases were dengue 
haemorrhagic  fever.  5 cases were dengue haemorrhagic  shock. 
7. Other cases diagnosed were malaria, leptospirosis, typhoid, septicaemia, 
HIV, miliary tuberculosis, haematological malignancy. 
8. Out of 21 cases, 19 cases were p.vivax  and 2 cases were p.falciparum. 
9. Among 100 cases, most of  the patients with platelet count above 
40,000,  17 cases between 20,000 to 40,000., 23 cases  had platelet 
below 20,000. 
                                                                                    
 
 
10. Clinical manifestation of the thrombocytopenia  are present only in 12 
cases out of 100 cases. 
11. Among 23 patients  with <20000 platelet count,  12 patients improved 
without platelet transfusion.  So, only 11 patients  actually  need blood 
transfusion. 
12. Out of 100 cases, 12 cases had elevated renal parameter. Out of this 12 
cases, 8 patients renal parameter improved with rehydration alone. Only 
4 cases  who needed nephrologist’s intervention and dialysis. 
13. In general, 92 cases had recovered and 8 cases had expired. 
14. In  92  cases who had good recovery 45 cases followed up and platelet 
count reached normal at the time of discharge. 
 
                    
 
 
 
 
 
 
 
 
 
 
                                                                                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion 
 
                                                                                    
 
 
CONCLUSION 
1. Fever with thrombocytopenia is one of the most challenging problems in 
the field of medicine. 
2. Fever with thrombocytopenia consists of occult presentation of common 
disease rather than rare disease. 
3. Infection is the most common cause of fever with thrombocytopenia. 
4. Dengue, malaria, leptospirosis still present clinically in atypical and 
occult form, making diagnosis more difficult. So high index of clinical 
suspicion  is needed. 
5. So other than routine investigation they should do specific test like rapid 
spot test, IgM ELISA for dengue, IgM ELISA leptospirosis antibodies, 
widal test etc for correct diagnosis. 
6. In majority of the patient, thrombocytopenia without bleeding 
manifestation. 
7. Generally , spontaneous bleeding was noted in platelet count <20,000 , 
even some patients not have any bleeding manifestation  with this 
platelet count. But  due to qualitative defect it was seen in platelet count 
in the range of   40,000 cell cu/mm also. 
8. Even with platelet count less than 20,000, platelet transfusion is not 
needed for all the cases. 
9. Overall mortality for fever with thrombocytopenia  is  8%. 
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Appendix 
 
                                                                                    
 
 
PROFORMA       
 
“ A STUDY OF CLINICAL PROFILE, LABORATORY 
PROFILE AND COMPLICATION OF FEVER WITH 
THROMBOCYTOPENIA” 
 
NAME :                        AGE:         SEX:             IP NO: 
 
DOA:                          OCCUPATION:                       PLACE: 
SYMPTOMS AND SIGN:  
 FEVER                                    
 CHILLS AND RIGOR 
 MYALGIA                                  
 HEADACHE 
 ABDOMINAL PAIN                      
 VOMITING 
 DIARRHOEA/ CONSTIPATION      
 COUGH  
 BREATHLESSNESS                       
 RASHES 
 BLEEDING GUM                         
 PETECHIAE 
 GI  BLEED                                    
                                                                                    
 
 
 HEMATURIA 
 OLIGURIA                           
 ALTERED SENSORIUM 
 CONJUCTIVAL SUFFUSION         
 LOSS OF WEIGHT 
 DEHYDRATION                      
 ANAEMIA 
 LYMPHADENOPATHY                
 VITAL SIGNS 
 HEPATOMEGALY                  
 SPLENOMEGALY 
 ADDED SOUNDS IN LUNGS 
 
INVESTIGATIONS: 
 
BLOOD SUGAR  : 
                  UREA : 
   Sr. CREATININE : 
 ELECTROLYTES : 
   
COMPLETE  BLOOD COUNT: 
                
                          Hb     :          g % 
                             TC   :     cells/µL 
                             DC   :           P: ,      L: ,     E: % 
                      Platelets  :          cells/micro Ltr 
               haematocrit: 
                          RBC   :          cells/µL 
                          ESR   :           ½ hr: mm 
        :  1 hr: mm 
  
                                                                                    
 
 
URINE ROUTINE 
 
Albumin : 
Sugar   : 
Deposits : 
Bile Salts : 
Bile Pigments: 
           
    LIVER FUNCTION TEST 
              Date:                                          Day 1                      After 1 week 
 
       Total Bilirubin  mg/dl 
       Direct Bilirubin  mg/dl 
       Indirect Bilirubin  mg/dl 
       SGOT  U/L 
       SGPT  U/L 
       Sr.Alkaline Phosphatase:  IU 
 
Peripheral smear:                                         Peripheral smear for MP: 
  
Dengue serology:                                         IgM Antibody for leptospirosis: 
Widal test:                                                     Sputum AFB 
HIV 1 AND 2:                                          BLOOD CULTURE: 
URINE CULTURE:                                 USG ABDOMEN: 
X RAY CHEST AND ECG:    
BONE MARROW ASPIRATION: 
Fundus:                                                    
Blood transfusion: 
Diagnosis: 
 
Prognosis: 
                                                                                    
 
 
ABBREVATIONS: 
   
DHF-   DENGUE  HAEMORRAGHIC  FEVER 
DHS  -    DENGUE HAEMORRAGHIC SHOCK 
MAL  -      MALARIA 
LEPTO -    LEPTOSPIROSIS 
TYP  -        TYPHOID 
SEPT  -      SEPTICAEMIA  
CML  -      CHRONIC  MYELOID  LEUKAEMIA. 
CLL  -      CHRONIC  LYMPHOCYTIC  LEUKAEMIA. 
UNS  -     UNSPECIFIED  ( VIRAL FEVER) 
M TB  -     MILIARY TUBERCULOSIS  
PANCYT -       PANCYTOPENIA. 
CYTOP -     CYTOPENIA. 
P.VIVAX -        PLASMODIUM  VIVAX. 
P.FALCI -          PLASMODIUM   FALCIPARUM. 
GB  -        GALL BLADDER THICKENED. 
FF  -  FREE FLUID 
B/L PE -      BILATERAL PLEURAL EFFUSION 
HM  -          HEPATOMEGALY 
SM  -           SPLENOMEGALY. 
HSM  -          HEPATOSPLENOMEGALY. 
C. PYLEO -         CHRONIC PYELONEPHRITIS. 
PLT  -     PLATELET COUNT. 
PC  -      PACKED CELL /  FFP   FRESH FROEN PLASMA 
GI   –  GASTRO INTESTINAL BLEED 
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SI NO 
 
 
 
 
 
NAME 
A
G
E
 
S
E
X
 
 
 
 
 
 
DOA 
 
 
 
 
 
IP NO 
F
E
V
E
R
 
D
U
R
A
T
I
O
N
 
C
H
I
L
L
S
/
 
 
R
I
G
O
R
 
M
Y
A
L
G
I
A
 
A
B
D
 
P
A
I
N
 
V
O
M
I
T
I
N
G
 
C
O
U
G
H
/
 
E
X
P
 
G
U
M
 
B
L
E
E
D
 
P
E
T
E
C
H
I
A
E
 
G
I
T
 
B
L
E
E
D
 
L
O
S
S
 
 
 
W
T
 
C
O
N
J
 
 
S
U
F
F
U
S
I
O
N
 
A
L
T
E
R
E
D
 
S
E
N
S
O
R
I
U
M
 
D
E
H
Y
D
R
A
T
I
O
N
 
O
L
I
G
U
R
I
A
 
D
Y
S
P
N
O
E
A
 
P
A
L
L
O
R
 
J
A
U
N
D
I
C
E
 
H
Y
P
O
T
E
N
S
I
O
N
 
H
E
P
A
T
O
M
E
G
A
L
Y
 
S
P
L
E
E
N
O
M
E
G
A
L
Y
 
P
L
E
U
R
A
L
 
E
F
F
U
S
I
O
N
 
A
D
D
 
S
O
U
N
D
 
F
U
N
D
U
S
 
1 JAYAMANI 34 F 14/1/11 1337 P 7 - - - - - P P - - - - p - - - - - - - - - N 
2 MURUGAN 30 M 15/1/11 1478 P 5 P - P - - - - - - - - -- - - - - - - - - - N 
3 DURAI 45 M 15/1/11 1596 P 5 - P - - - - - - - - - - - - - - - - - - - N 
4 SAMPATH 32 M 17/1/11 2775 p 5 - P - - - - P P  P - P - - - P P - - - - H 
5 RAGUPATHI 27 M 19/1/11 2856 P 4 P - P P - - - - - - - - - - - - - - - - - N 
6 KUMAR 35 M 24/1/11 4070 P 3 P - - P - - - - - - - P - - - - - - - - - N 
7 ISFMAIL 44 M 15/2/11 6112 P 4 - P - - - - - - - - - P - - - - - - - - - N 
8 KACHANA 33 F 28/2/11 8462 P 7 - P - - - - - - - - - P - - - - - - - - - N 
9 ANTONY 30 M 13/3/11 12352 P 7 - P - - - - - - - - - - - - - - - - - - - N 
10 MANIKANDAN 39 M 8/4/11 19391 P 8 P - P - - - P - - - - P - P - P - - - P P N 
11 SARAVANAN 28 F 15/4/11 21384 P 40 P P - - P P - - P - P P - P P - - P - - P N 
12 SIVARAJ 34 M 5/5/11 24362 P 30 P - - - P - - - P - - - - P P - - - - P P N 
13 SHAJAHAN 37 M 9/6/11 26742 P 10 P - P - - - - - - - - P - - - - - - - - - N 
14 PONNUSAMY 62 M 15/6/11 36014 P 30  P P - - P P P P - P P P P P - P P - - - H 
15 MANI 38 M 18/6/11 36456 P 6 P - - - - - - - - - - - - - - - - -- - - - N 
16 KALIYAPPAN 60 M 30/6/11 37114 P 45 - P P - - P - - P - - - P - P - - P - - - N 
17 SATIYAMURTY 22 M 10/7/11 38985 P 7 P - - P - - - - - - - P - - P - - - - - - N 
18 GURUSAMY  42 M 13/7/11 39124 P 8 - P - P P P P - - - P P P P - - P P - P P H 
19 ANIFA 36 F 20/7/11 43432 P 4 P P - - - - - - - - - - - - - - - - - - - N 
20 KARTHICK 19 M 24/7/11 45760 P 2 - - - - - - - - - - - - - - - - - - - - - N 
21 SHANMUGAM 29 M 27/7/11 46436 P 35 P - P P P - - - P - - P - - P - - P - - P N 
22 SAYETH ABAS 14 M 30/7/11 43074 P 3 - P P P - - - - --- - - - P - - - - - - - - N 
23 PADHMINI 44 F 2/8/11 47126 P 4 P P - - - - - - - - - - - - - - - - - - - N 
24 DEVIKA 26 F 8/8/11 47764 P 15 - P P P - - - - - - - P - - - - - - - - - N 
25 KUPUSAMY 36 M 13/8/11 47926 P 5 P -- - - - - - - - - - - - - - - - - - - - N 
26 NAGALINGAM 40 M 18/8/11 48412 P 3 - - - - - - - - - - - P - - - - - - - - - N 
27 SIVAKUMAR 29 M 28/8/11 49136 P 4 P P P - - - - - - - - - - - - - - - - - - N 
28 MUNUSAMY 40 M 5/9/11 49360 P 7 - - - - - - - - - - - - - - - - - - - - - N 
29 RAMESH 34 M 13/9/11 51915 P 5 P - - - - - -  - - - - - P - - - - P P P N 
30 KARIYAN 35 M 17/9/11 52659 P 7 P P P - - - P - - - - P - - - - - - - - - N 
31 MARIYAPPAN 40 M 6/9/11 50299 P 8 P P P - - P P - - P - P - P - - - - P P P N 
32 BASHEER 60 M 3/9/11 49486 P 10 P - - - - - - - - - - P P - - - P - - - - N 
33 KAVITHA 24 F 16/9/11 52441 P 14 P - P P - - - - - - - - - P - - - - - P P N 
34 ERAMMA 36 F 22/9/11 53732 P 7 P - P P P - P - - - P P - P P - - - P P P H 
35 NISHA 22 F 24/9/11 54130 P 8 P P - - - - - - - - - - -- - - - - -- - - - N 
36 MUTHURAJ 41 M 26/9/11 54789 P 15 P P - P - P P - - P P P P P - P P P P - P H 
37 SIVASHANKAR 28 M 28/9/11 55134 P 14 - - P P - - - - - - - - - - - - - - - - - N 
38 RABIK 22 M 1/10/11 55781 P 7 - P - - - - - - - - - - - - - - - - - - - N 
39 TAMIL ARASU 30 M 3/10/11 51678 P 6 P P - - - - - - - - - - - - - - - - - - - N 
40 AISHA 43 F 5/10/11 50225 P 35 - P P - - P - - P - - - - - P - - P P - - N 
41 LAKSHMI 52 F 5/10/11 50289 P 14 P P P P - - - - - - P P P - -- - - - - - - N 
42 RAMYA 25 F 6/10/11 51657 P 4 P P - - - - - - - - -- - - - - - - - - - - N 
43 SELVARAJ 36 M 6/10/11 53278 P 4 P P - - - - - - - - - - - - - - - - - - - N 
44 CHINNU 45 M 7/10/11 52456 P 7 P - - - - - - - - -- - P - - - - - - - - - N 
45 SHAJAHAN 40 M 7/10/11 51786 P 35 P P - - - - - - P - P - - P P - - - - - P N 
46 RAJAMMAL 36 M 8/10/11 52145 P 5 P P - - - - - - - - - - - - - - - - - - - N 
47 SUNDARAM 32 M 8/10/11 53789 P 7 P - - - - - - - - - - - - - - - - - - - - N 
                                                                                    
 
 
48 MANOHARAN 30 M 9/10/11 53419 P 4 P P - - - - - - - - - P - - - - - - - - - N 
49 MADHESH 31 M 10/10/11 55661 P 15 - P - - - - - - - P - P - - - P - - - - - N 
50 GOMATHY 60 F 15/11/11 64857 P 3 - - P P - - - -- - - - P P - P - P P - - - N 
51 RAMATHAL 63 F 17/11/11 57767 P 45 - P P - - - - - P - P P - - P - - - - - - N 
52 ARUMUGAM 25 M 19/11/11 65805 P 10 P - P P - - - - - - - P - - - - - - - - - N 
53 RAJA 34 M 12/11/11 64200 P 14 P P P P - - - - - P - - - -- - P - P - - - N 
54 PALANI 41 M 13/11/11 64231 P 8 P - - - - - - - - - - - - - - - - - - - - N 
55 KRISHNAN 29 M 13/11/11 65879 P 6 P P - - - - - - - - - - - - - - - - - - - N 
56 RAJESH 26 M 13/11/11 65467 P 10 - P   - - - -  P - -- - - - P - - - - - N 
57 RANI 38 F 14/11/11 63278 P 3 - P - - - - - - - - - - - - - - - - - - - N 
58 UNNI 28 M 14/11/11 64534 P 6 P P - - - - - - - - - - - - - - - - - - - N 
59 SAKTHIVEL 30 M 15/11/11 65231 P 3 P - - - - - - - - - - - - - - - - - - - - N 
60 SANKAR 26 M 15/11/11 65347 P 5 - P - - - - - - - - - - - - - - - - - - - N 
61 SURYA 18 M 15/11/11 65785 P 7 P - - - - - - - - - - - - - - - - - - - - N 
62 VIJI 29 M 15/11/11 65245 P 5 - P - - - - - - - - - - - - - - - - -- - - N 
63 ANITHA 24 F 15/11/11 65765 P 8 P P - P - - P - - P - P - P - - P P - P P N 
64 SRIDHAR 27 M 16/11/11 65197 P 15 - - P P - - - - - - - P - - - - - - P - - N 
65 BOOPATHI 21 M 16/11/11 66129 P 4 - P - - - - - - - - - - - - - - - - - - - N 
66 SURESH 19 M 16/11/11 66321 P 8 P - - - - - - - - - - - - - - - - - - - - N 
67 KARUPAN 38 M 16/11/11 66078 P 7 P - P P - - - - - - P P P - - - P - - - - N 
68 RAMALAKSHMI 21 F 16/11/11 66749 P 5 P P - P - - - - - - - P - - - - - - - - - N 
69 SANGEETHA 18 F 16/11/11 66758 P 5 P P - P P - P P - - P P - P - - P - - - P N 
70 JAYA 18 F 16/11/11 66850 P 7 P P - - - - - - -- - - - - - - - - - - - - N 
71 SIVA SHANKAR 22 M 17/11/11 67123 P 3 P P - - - - - - - - - - - - - - - - - - - N 
72 RAJA 26 M 17/11/11 67345 P 6 - P - - - - - - - - - - - - - - - - - - - N 
73 RANGAN 26 M 17/11/11 67231 P 14 - P   - P    P  P - - - P - - - - - N 
74 JAFFER 29 M 17/11/11 67432 P 10 - P - - P P - - - P - P P P - P P - - P P H 
75 PANNEER 40 M 17/11/11 67489 P 8 P - - - - - - - - - - - - - - - - - - - - N 
76 MADHAN 31 M 17/11/11 68145 P 9 - P - - - - - - - - - - - - - - - - - - - N 
77 ARAVINDH 27 M 18/11/11 68254 P 6 - - - - - - - - - - - P - - - - - - - - - N 
78 SELVI 26 F 18/11/11 68367 P 6 - - - - - - - - - - - - - - - - - - - - - N 
79 SENTHIL 29 M 18/11/11 68167 P 7 P P - - - - - - - - - - - - - - - - - - - N 
80 KANDASAMY 40 M 18/11/11 68289 P 14 - P - - - - - - - P - - - - - P - - - - - N 
81 KANNIYAPAN 45 M 18/11/11 68356 P 40 P - - - - - - - P - P P - - - - - - - - - N 
82 MARY 36 F 18/11/11 68412 P 2 P P - - - - - - - - - - - - - - - - - - - N 
83 SENTHIL 37 M 18/11/11 67356 P 12 - P - - - - - - - - - - - - - - - - P - - N 
84 RAVI 44 M 19/11/11 61239 P 34 P - - - - - - - P - - - - - - - - - - - - N 
85 GOWRI 23 F 19/11/11 61849 P 3  P - - - - - - - - - - - - - - - - - - - N 
86 PONNUSAMY 62 M 19/11/11 61987 P 5 - P - - - - - - - - - - - - - - - - - - - N 
87 ANGALASWARI 19 F 20/11/11 66200 P 10 P P P P P - P - - - P P - P - - P - - - P N 
88 HARI 24 M 21/11/11 66128 P 6 - P - - - - - - - - - - - - - - - - - - - N 
89 SUJA 30 F 22/11/11 63778 P 7 P - - - - - - - - - - -  - - - - - - - - N 
90 THANGAM 18 F 27/11/11 66236 P 8 P P - - - - - - - - - P - - - - - - - - - N 
91 SUDHA 18 F 27/11/11 66246 P 5 P P P - - - - - - - - - - - - - - - - - - N 
92 MAHESWARI 19 F 27/11/11 63246 P 6 P P - - - - - - - - - - - - - - - - - - - N 
93 RAMALAKSHMI 20 F 27/11/11 66208 P 5 P P - - - - - - - - - - - - - - - -- - - - N 
94 VELDURAI 45 M 27/11/11 67552 P 30 P P P - - - - - P - - - - - P - - - P - - N 
95 RAVI 46 M 27/11/11 68918 P 14 P P - - - - - - - P - - - - - P - - - - - N 
96 SANTHIYA 21 F 27/11/11 67418 P 3 P P - - - - - - - - - P - - - - - - - - - N 
97 RANGITHAM 40 F 28/11/11 62567 P 10 - - P P - - - - - - - - - - - - - - - - - N 
98 GANESH 37 M 28/11/11 64346 P 6 P P - - - - - - - - - - - - - - - - - - - N 
99 PANDISHWARI 18 F 28/11/11 67325 P 3 P P - - - - - - - - - - - - - - - - - - - N 
100 MANIKAM 38 M 28/11/11 67456 P 4 P - P - - - - - - - - - - - - - - - - - - N 
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1 JAYAMANI 12 5.8 20,000 34 22 1.2 34 23 67 23 1.1 - P - - - - - - N N  N  3 FFP C DHF 
2 MURUGAN 11 7.9 67,000 45 21 1.4 33 45 56 34 1.3 P - - - - - - - P.VIVAX MILD HM N - - C MAL 
3 DURAI 13.4 13.3 44,000 40 34 1.3 21 26 66 21 1.0 - P - - - - - - N N N - - C DHF 
4 SAMPATH 15 6.3 19,000 38 34 18 360 250 140 24 0.8 - - P - - - - - N N N  1PLT,2FFP C LEPT 
5 RAGUPATHI 11.9 5.8 77,000 36 25 1.6 23 34 88 34 0.9 - - - P - - - - N N N - - C TYP 
6 KUMAR 15.8 5.7 40000 45 30 1.4 34 27 56 29 0.7 - P - - - - - - N GB/ FF+ N - 1PLT,2FFP C DHF 
7 ISHMAIL 12.8 6.7 120000 37 24 1.2 35 44 89 21 1.5 - P - - - - - - N N N - - C DHF 
8 KACHANA 13.8 14.2 45,000 36 22 1.1 44 28 92 25 1.1 - P - - - - - - N N N - - C DHF 
9 ANTONY 10.8 11.5 65,000 32 34 1.5 56 45 90 24 1.6 - P - - - - - - N N N - - C DHF 
10 MANIKANDAN 12.2 9.2 7500 40 15 2.3 83 97 113 32 1.6 P - - - - - - - P.VIVAX HSM B/L PE - 4 PLT C MAL 
11 SARAVANAN 8.7 14.6 28,000 55 78 1.8 45 34 78 27 1.1 - - - - - P - - CYTOPENIA HM N - 1PC C HIV 
12 SIVARAJ 9.1 15.1 55,000 34 88 1.2 34 46 77 34 1.3 - - - - P - - - CYTOPENIA N M. TB - - C M.TB 
13 SHAJAHAN 10.2 7.2 5,500 30 24 1.0 40 33 55 36 1.3 P - - - - - - - P.VIVAX N N - - C MAL 
14 PONNUSAMY 6.4 2.7 6,500 55 20 1.2 45 28 60 39 1.0 - - - - - - - - PANCYTO MILD HM N AML 2PC/ 4PLT E AML 
15 MANI 12.4 6.7 45,000 38 23 1.3 56 34 67 24 1.1 - P - - - - - - N GB / FF+ N - - C DHF 
16 KALIYAPPAN 7.4 3.3 39,000 35 15 1.4 55 45 58 24 0.8 - - - - - - - - PANCYTO MILD HM N AML 2PC/1PLT C AML 
17 SATIYAMURTY 9.7 7.5 12,000 24 25 1.8 44 36 70 30 0.9 - P - - - - - - N N N - 2PLT C DHF 
18 GURUSAMY 12.1 14.5 14,000 55 24 1.2 45 48 78 88 2.8 - P - - - - - - N GB/ FF+ B/L PE PE 2PLT/2FFP C DHS 
19 ANIFA 12.8 12.1 56,000 34 12 1.1 23 34 98 24 1.4 P - - - - - - - P.VIVAX N N - - C MAL 
20 KARTHICK 11.8 97 75,000 30 24 1.2 34 49 67 34 1.1 - P - - - - - - N N N - - C DHF 
21 SHANMUGAM 8.8 2.4 36,000 35 60 1.5 45 65 77 25 0.8 - - - - - P - - PANCYTO MILD HM N - 2PC C HIV 
22 SAYETH ABAS 12.7 4.1 85,000 34 20 1.0 40 45 78 36 1.4 - P - - - - - - N N N - - C DHF 
23 PADHMINI 12.2 6.6 66,000 24 22 1.1 45 34 89 34 1.1 P - - - - - - - P. VIVAX N N - - C MAL 
24 DEVIKA 12.4 5.6 58,000 34 12 1.1 34 45 78 36 0.9 - - - P - - - - N MILD SM N N - C TYP 
25 KARUPUSAMY 11.9 6.7 52,000 43 20 1.7 45 23 88 34 0.8 - P - - - - - - N N N N - C DHF 
26 NAGALINGAM 12.9 11.4 66,000 34 18 1.4 33 24 78 23 0.9 - P - - - - - - N N N N - C DHF 
27 SIVAKUMAR 13.1 13.5 75,000 40 23 1.5 34 45 79 34 1.4 - P - - - - - - N N N N - C DHF 
28 MUNUSAMY 12.4 11.3 110000 44 24 1.3 55 34 99 28 1.5 - P - - - - - - N N N N - C DHF 
29 RAMESH 10.6 5.5 78,000 55 23 1.1 55 34 67 28 1.3 P - - - - - - - P.VIVAX  SM/ FF+ B/L PE - - C MAL 
30 KARIYAN 11.5 7.7 12,000 40 21 1.6 41 43 71 29 1.0 - P - - - - - - N N N - - C DHF 
31 MARIYAPPAN 12.5 6.1 40,000 41 34 1.2 35 45 65 36 0.8 - - P - - - - - N SM B/L PE - - C LEPT 
32 BASHEER 12.7 7.1 35,000 23 12 1.1 45 56 77 55 2.0 P - - - - - - - P.VIVAX N N - - C MAL 
33 KAVITHA 10.8 3.6 28,000 55 23 1.3 34 41 65 46 1.8  - - P - - - - N FF+ B/L PE - - C TYP 
34 ERAMMA 9.3 11 10,000 50 18 5.8 214 148 179 114 4.9 P - - - - - -- - P.FALCI SM ARDS - 2PLT/2FFP E MAL 
35 NISHA 12.1 5.5 99,000 24 12 1.1 35 51 66 27 0.8 - P - - - - - - N N N - - C DHF 
36 MUTHURAJ 11.4 7.9 15,000 50 40 7.5 188 110 143 180 4.6 - - P - - - - - N HSM N - 2PLT/2FFP E LEPT 
37 SIVASHANKAR 13.4 14.6 77,000 24 21 1.3 34 45 79 34 1.1 - - - P - - - - N N N N - C TYP 
38 RABIK 12.4 12 55,000 34 22 1.1 22 45 56 34 0.9 - P - - - - - - N N N - - C DHF 
39 TAMIL ARASU 10.6 18 10,000 35 20 1.7 45 35 89 35 1.2 P - - - - - - - P.FALCI N N N - C MAL 
40 AISHA 6.5 1.00 65,000 35 15 1.5 34 46 89 30 1.1 - - - - - - - - CML -AP MOD HSM N CML- AP 2PC C CML 
41 LAKSHMI 11.3 15.6 54,000 45 56 1.3 35 45 78 170 3.5 - - - - - - - P N CH.PYLEO N - - E SEPT 
42 RAMYA 12.3 7.8 65,000 34 12 1.2 45 34 76 34 1.1 - - - - - - - - N N N N - C UNS 
43 SELVARAJ 13.4 7.3 78,000 24 10 0.9 55 23 89 29 0.8 - - - - - - - - N N N N - C UNS 
                                                                                    
 
 
 
 
 
44 CHINNU 14.5 13.4 40,000 25 12 0.8 34 45 67 34 1.4 - P - - - - - - N N N  - C DHF 
45 SHAJAHAN 8.9 13.2 55,000 34 87 3.1 55 66 119 28 1.5 - - - - P - - - CYTOPENIA N M. TB - - E M.TB 
46 RAJAMMAL 12.4 5.6 78,000 28 13 1.4 54 28 78 34 1.1 - P - - - - - - N N N - - C DHF 
47 SUNDARM 12.5 7.4 120000 35 20 1.7 22 38 90 21 1.3 - P - - - - - - N N N - - C DHF 
48 MANOHARAN 11.6 8.9 34,000 24 12 1.3 45 56 77 27 1.4 - P - - - - - - N THICK GB N - - C DHF 
49 MADESH 13.3 3.5 22,000 42 13 3.1 98 112 134 34 1.6 - - P - - - - - N N N - - C LEP 
50 GOMATHY 11.3 9.7 11,000 30 10 1.5 48 150 54 134 3.2 - -  P - - - - N MILD HM N N 2FFP C TYP 
51 RAMATHAL 4.8 1,53 36,000 34 56 1.6 45 34 88 20 0.7 - - - - - - - - CLL- SMUDGE  SM N CLL 2PC E CLL 
52 ARUMUGAM 13.7 4.1 100000 35 15 1.4 50 55 89 34 1.3 - -  P - - -- - N MILD HM N - - C TYP 
53 RAJA 11.1 9.4 89,000 38 10 8.9 293 336 114 20 0.9 - - P - - - - - N MILD HM N - - C LEPT 
54 PALANI  13.5 5.6 77,000 23 21 1.3 34 56 87 24 0.8 P - - - - - - - P.VIVAX  N - - C MAL 
55 KRISHNANA 12.9 7.7 55,000 34 23 1.1 45 67 89 34 0.7 P - - - - - - - P.VIVAX N N - - C MAL 
56 RAJESH 11.4 14.1 22,000 35 21 3.1 112 134 105 24 1.5 - - P - - - - - N N N - - C LEPT 
57 RANI 12.5 11.5 18,000 36 16 1.1 45 28 78 26 1.2 - P - - - - - - N N N - - C DHF 
58 UNNI 13.8 12.4 23,000 40 23 1.2 45 56 78 24 1.5 - - - - - - - - N N N - - C UNS 
59 SAKTHIVEL 12.6 12.5 45,000 34 25 1.4 34 37 76 27 0.9 P - - - - - - - P. VIVAX N N - - C MAL 
60 SANKAR 13.4 14.5 18,000 36 13 1.4 45 34 89 29 1.4 P - - - - - - - P.VIVAX N N - - C MAL 
61 SURIYA 12.4 5.5 10,000 34 11 1.5 56 67 98 34 1.2 P - - - - - - - P.FALCI N N - - C MAL 
62 VIJI 13.9 6.7 56,000 24 23 1.4 45 36 78 35 1.5 - P - - - - - - N N N - - C DHF 
63 ANITHA 10.4 13.6 12,000 56 34 1.3 56 66 89 38 1.6 - P - - - - - - N MILD HM B/L PE - 2 FFP C DHS 
64 SRIDHAR 12.3 3.2 45,000 34 32 1.6 45 44 78 24 1.2 - - - P - - - - N SM N - - C TYP 
65 BOOPATHI 13.2 4.6 18,000 28 21 1.4 45 56 90 28 1.5 - P - - - - - - N N N - - C DHF 
66 SURESH 11.8 5.8 33,000 32 12 1.2 34 56 67 34 1.2 P - - - - - - - P.VIVAX N N N - C MAL 
67 KARUPAN 10.3 15.6 55,000 56 55 1.8 56 77 90 88 3.2 - - - - - - - P - C. PYLEO N N - C SEPT 
68 RAMALAKSMI 12.4 6.7 120200 28 15 1.7 45 33 80 34 1.2 - P - - - - - - N N N - - C DHF 
69 SANGEETHA 13 13.7 14,000 55 25 1.6 56 60 90 24 1.5 - P - - - - - -- N N B/L PE - 6PLT/3FFP C DHS 
70 JAYA 13.9 5.1 100000 34 33 1.1 44 45 78 33 0.8 - P - - - - - - N N N - - C DHF 
71 SIVASHANKAR 12.4 12.4 44,000 23 21 1.4 34 56 67 34 0.7 - P - - - - - - N N N - - C DHF 
72 RAJA 13.4 5.8 78,000 21 19 1.1 36 59 81 50 2.4 - P - - - - - - N N N - - C DHF 
73 RANGAN 10.4 3.5 13,000 32 17 3.8 101 89 76 23 1.3 - - P - - - - - N N N - 2FFP C LEPT 
74 JAFFER 12.4 6.7 11,000 57 34 6.7 123 142 90 142 3.7 - - P - - - - - N N CONSO - 2PLT/FFP E LEPT 
75 PANNEER  13.2 4.8 44,000 23 12 1.2 34 56 78 34 1.2 P - - - - - - - N N N - - C MAL 
76 MADHAN 11.2 5.6 51,000 27 19 1.4 25 58 72 38 1.2 P - - - - - - - N N N - - C MAL 
77 ARAVIND 13.4 9.9 19,000 25 15 1.8 43 56 87 25 1.1  P - - - - - - N N N - - C DHF 
78 SELVI 11.9 12.3 43,000 32 14 1.2 34 45 88 43 1.8 - P - - - - - - N N N - - C DHF 
79 SENTHIL 13.6 5.6 77,000 23 19 1.3 33 76 90 34 1.3 P - - - - - - - N N N - - C MAL 
80 KANDASAMY 12.4 3.4 47,000 34 10 3.5 43 56 87 36 1.6 - - P - - - - - N N N - - C LEPT 
81 KANNIYAPPAN 8.9 2.7 35,000 35 55 1.6 56 67 98 27 1.6 - - - - - P - - PANCYTO N N N 2PC E HIV 
82 MARY 12.4 6.8 89,000 23 12 1.7 34 65 90 34 1.3 - - - - - - - - N N N N - C UNS 
83 SANTHI 12.4 3.5 77,000 26 13 3.2 45 56 89 26 1.4 - - P - - - - - N SM N - - C LEPT 
84 RAVI 8.9 2.7 45,000 26 14 1.4 34 25 79 34 1.5 - - - - - P - - PANCYTO N N N 2PC C HIV 
85 GOWRI 13.4 6.8 55,000 28 19 1.6 39 56 90 59 2.2 P - - - - - - - P.VIVAX N N N - C MAL 
86 PONNUSAMY 12.4 8.9 79,000 28 24 1.3 45 67 89 34 1.6 - P - - - - - - N N N N - C DHF 
87 ANGALESWARI 13.1 7.4 10,000 57 30 1.4 54 55 88 60 2.4 - P - - - - - - N N ARDS - 4PPT/2FFP C DHS 
88 HARI 11.1 8.8 57,000 30 21 1.3 45 59 79 31 1.1 - P - - - - - - N N N - - C DHF 
89 SUJA 12.5 7.9 88.000 31 23 1.5 47 61 91 33 1.3 P - - - - - - - P.VIVAX N N N - C MAL 
90 THANGAM 11.9 8.9 19,000 24 23 1.2 34 47 100 38 0.9 - P - - - - - - N N N - 3PLT/3FFP C DHS 
91 SUDHA 12.5 5.5 80,000 25 22 1.3 35 59 78 24 0.8 - P - - - - - - N N N - - C DHF 
92 MAHESWARI 13 7.1 50,000 34 12 1.4 45 26 69 34 1.3 - P - - - - - - N N N - - C DHF 
93 RAMALAKSMI 14 9.4 22,000 44 18 1.2 54 45 79 28 0.9 - P - - - - - - N N N - 3FFP C DHF 
94 VELDURAI 8.9 33.4 45,000 36 15 1.5 45 55 98 36 1.2 - - - - - - - - NHL MOD SM N NHL 2PC C NHL 
95 RAVI 11.1 4.4 50,000 45 30 5.3 36 45 90 34 1.6 - - P - - - - - N N N - - C LEPT 
96 SANTHIYA 12.8 5.7 61,000 47 39 1.7 55 56 89 24 1.1 - P - - - - - - N N N - - C DHF 
97 RANGITHAM 11.4 3.1 34,000 43 33 1.3 51 57 90 36 1.4 - - - P - - - - N N N - - C TYP 
98 GANESH 12.4 7.8 55,000 39 23 1.2 45 67 89 23 1.2 P - - - - - - - N N N - - C MAL 
99 PANDISHWARI 13.4 7.9 90,000 24 23 1.1 45 49 88 38 1.3 - P - - - - - - N N N - - C DHF 
100 MANIKAM 12.8 6.9 45,000 25 21 1.6 34 67 78 34 1.4 - - - - - - - - N N N N - C UNS 
